About the Authors
- Eva Wex
-
Affiliation Boehringer Ingelheim Pharma GmbH & Co. KG, Respiratory Diseases Research, Biberach a. d. Riss, Germany
- Thierry Bouyssou
-
* E-mail: thierry.bouyssou@boehringer-ingelheim.com
Affiliation Boehringer Ingelheim Pharma GmbH & Co. KG, Respiratory Diseases Research, Biberach a. d. Riss, Germany
Competing Interests
The authors of this manuscript have the following competing interests: EW and TB are employees of Boehringer Ingelheim Pharma GmbH & Co. KG, the developer of olodaterol and the funder of the study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: EW TB. Analyzed the data: EW TB. Wrote the paper: EW TB.